Ozempic vs Zepbound: Price & Results Breakdown (2026)
Trying to choose between Ozempic (Semaglutide) and Zepbound (Tirzepatide)? Below we put the trial weight loss numbers, monthly cost, dosing, and tolerability head to head — and spell out the type of patient each one tends to fit best.
Ozempic (Semaglutide, GLP-1 receptor agonist) and Zepbound (Tirzepatide, Dual GLP-1/GIP receptor agonist) work through different mechanisms. Ozempic is FDA-approved for type 2 diabetes with 8-14% of body weight average weight loss at $998/mo. Zepbound is approved for chronic weight management with 20-22% of body weight average weight loss at $1,060/mo.
The Numbers at a Glance
| Feature | Ozempic | Zepbound |
|---|---|---|
| Active Ingredient | Semaglutide | Tirzepatide |
| Mechanism | GLP-1 receptor agonist | Dual GLP-1/GIP receptor agonist |
| FDA Approved For | Type 2 diabetes | Chronic weight management |
| Doses | 0.25mg, 0.5mg, 1mg, 2mg (weekly injection) | 2.5mg to 15mg (weekly injection) |
| Administration | Weekly subcutaneous injection | Weekly subcutaneous injection |
| Avg. Weight Loss | 8-14% of body weight | 20-22% of body weight |
| Monthly Price | $998 | $1,060 |
| Oral Available | No | No |
| Year Approved | 2017 | 2023 |
Figures shown are typical cash-pay prices before insurance. What you pay can differ by pharmacy, region, and your specific plan. Last updated March 2026.
Which Drops More Weight?
Based on clinical data, Zepbound produces more weight loss on average (20-22% of body weight) compared to Ozempic (8-14% of body weight). Ozempic relies on Semaglutide (GLP-1 receptor agonist), whereas Zepbound uses Tirzepatide (Dual GLP-1/GIP receptor agonist) — a likely reason for the gap.
Cleared first for type 2 diabetes management, it is frequently prescribed off-label to support weight loss. Its active drug, semaglutide, is identical to what powers Wegovy.
Holds FDA approval for ongoing weight management and runs on the same compound as Mounjaro, tirzepatide. Among GLP-1 medications cleared today, it records the strongest average weight reduction.
Which Is Easier on Your Wallet?
At list price, Ozempic is the more affordable option at $998/month compared to $1,060/month for Zepbound. That said, what leaves your pocket swings hugely with your coverage. Ozempic with insurance: $25-$200/month typical copay. Zepbound with insurance: Varies by plan.
Introductory cash-pay rate from Novo Nordisk: $199/month
Eligible patients can access the LillyDirect program
How the Side Effects Stack Up
Ozempic (GLP-1 receptor agonist) and Zepbound (Dual GLP-1/GIP receptor agonist) bring on much the same digestive side effects, which top the list of what patients report:
- Nausea (most common for both medications)
- Diarrhea and vomiting
- Constipation
- Abdominal pain
- Decreased appetite
- Headache, fatigue, dizziness (less common)
Rarer but more serious risks for both drugs include pancreatitis, gallbladder complications, and kidney strain. Each also carries a boxed warning about medullary thyroid carcinoma seen in rodent studies. Go over your complete medical history with a clinician before you start either one.
So Which One Is Right for You?
There is no single winner — the right pick comes down to your diagnosis, what your plan covers, how much weight you want to lose, and how you feel about injections versus pills. Use the quick checklist below as a starting point:
- -You have type 2 diabetes (on-label use, better insurance coverage)
- -Cost is a concern ($998/month at list price)
- -You prefer the convenience of once-weekly dosing
- -Your primary goal is weight loss (FDA-approved indication)
- -You want the dual GLP-1/GIP mechanism for potentially greater efficacy
- -You prefer the convenience of once-weekly dosing
See Who Prescribes These at the Lowest Price
Browse vetted telehealth programs that can prescribe Ozempic, Zepbound, and other FDA-approved GLP-1 medications — ranked by what you will actually pay.
Common Questions, Answered
Can I switch from Ozempic to Zepbound?
It can be done, but only under a prescriber's guidance, since Ozempic and Zepbound rely on different active ingredients (Semaglutide vs Tirzepatide). Your clinician will set the right starting dose and titration plan for whichever medication you move to.
Which is better for weight loss: Ozempic or Zepbound?
Clinical data suggests Zepbound produces more weight loss on average (20-22% of body weight) compared to Ozempic (8-14% of body weight). However, individual results vary significantly based on dosing, diet, exercise, and metabolic factors.
Is Ozempic cheaper than Zepbound?
At list price, Ozempic ($998/month) is less expensive than Zepbound ($1,060/month). With insurance, costs vary significantly. Ozempic: $25-$200/month typical copay. Zepbound: Varies by plan.
Do Ozempic and Zepbound have the same side effects?
They overlap a lot. Stomach-related effects like nausea, diarrhea, vomiting, and constipation show up with both because they are typical of GLP-1 receptor agonists. That said, the different active ingredients mean how often and how strongly they hit can differ — talk through your history with a clinician to see which is the safer fit for you.
Does insurance cover Ozempic and Zepbound?
Coverage varies by plan. Ozempic is FDA-approved for type 2 diabetes — insurance coverage is typically better for on-label use. Zepbound is FDA-approved for chronic weight management. Check with your specific insurance plan and ask your doctor about prior authorization requirements.